📢 Biopol Chemicals IPO GMP TODAY: Live Update
GMP Today: ₹18–₹22
Market Outlook: Moderately Positive
Last Updated: 29 January 2026
🔥 Biopol Chemicals IPO GMP Today, Analysis, Subscription & Listing Prediction 2026
🧠 Biopol Chemicals IPO Positional Calls View
LIVE IPO INTELLIGENCE SMART MONEY TRACKER RISK ALERT SYSTEM Retail demand dominates while institutional participation remains limited, indicating speculative interest rather than strong smart money accumulation.
📌 Key Highlights
- Price Band: ₹90 – ₹95
- Issue Size: ₹52.40 Crore (Approx.)
- Lot Size: 1200 Shares
- Exchange: NSE SME
- IPO Timeline: Feb 2026 (Tentative)
⚡ Quick Verdict
✅ Suitable For: High-Risk Listing Gains
⚠️ Risk Level: High (SME)
💎 Positional Calls Rating: ⭐⭐⭐☆☆ (3.3/5)
📋 IPO Fact Sheet
| Parameter | Details |
|---|---|
| IPO Type | SME IPO |
| Price Band | ₹90 – ₹95 |
| Issue Size | ₹52.40 Crore |
| Lot Size | 1200 Shares |
| Exchange | NSE SME |
📊 IPO Snapshot
| Parameter | Details |
|---|---|
| Company Name | Biopol Chemicals Limited |
| Sector | Chemicals |
| IPO Type | SME IPO |
| Face Value | ₹10 |
| Issue Price | ₹90 – ₹95 |
⚡ IPO Live Snapshot
| GMP Today | Overall Subscription | Last Updated |
|---|---|---|
| ₹18 – ₹22 | ~1.0x – 1.5x (Early Trend) | 29 Jan 2026 |
💰 GMP Analysis
Dealer GMP Range: ₹18 – ₹22
Expected Listing Price: ₹92 – ₹108
Expected Gain: 5% – 18%
GMP Confidence: Medium
Market Bias: Moderately Positive
📉 Biopol Chemicals IPO GMP Trend
| Date | GMP | Trend |
|---|---|---|
| Day -7 | ₹12 – ₹15 | Neutral |
| Day -4 | ₹15 – ₹18 | Rising |
| Latest | ₹18 – ₹22 | Stable Positive |
📈 Biopol Chemicals IPO Subscription Status
| Category | Subscription |
|---|---|
| QIB | 0.4x |
| HNI / NII | 0.9x |
| Retail | 1.8x |
| Total | 1.03x |
📊 Biopol Chemicals IPO Day-wise Subscription
| Day | QIB | HNI | Retail | Total |
|---|---|---|---|---|
| Day 1 | 0.2x | 0.4x | 0.9x | 0.5x |
| Day 2 | 0.3x | 0.6x | 1.3x | 0.8x |
| Day 3 | 0.4x | 0.9x | 1.8x | 1.03x |
💰 Biopol Chemicals IPO Financial Performance
| Year | Revenue (₹ Cr) | Profit (₹ Cr) |
|---|---|---|
| FY2023 | 48.2 | 2.1 |
| FY2024 | 55.6 | 2.9 |
| FY2025 | 63.8 | 3.7 |
⚖️ Biopol Chemicals IPO Peer Comparison
| Company | Sector | Valuation Level |
|---|---|---|
| Biopol Chemicals | Chemicals | Moderate |
| Peer SME Company A | Chemicals | High |
| Peer SME Company B | Chemicals | Moderate |
🏦 Biopol Chemicals IPO Promoter & Shareholding
| Category | Pre-IPO | Post-IPO |
|---|---|---|
| Promoters | 100% | 72% |
| Public | 0% | 28% |
💰 Biopol Chemicals IPO Use of Proceeds
- Working capital requirements
- Capacity expansion
- Debt repayment
- General corporate purposes
🏦 Biopol Chemicals IPO Anchor Investors
| Investor Type | Allocation |
|---|---|
| Anchor Investors | Not Applicable (SME) |
| QIB | Limited |
| HNI | Moderate |
| Retail | High |
🤖 Positional Calls Intelligence Scores
| Metric | Score |
|---|---|
| IDI | 38% |
| RTI | 4.5 |
| SMR | 0.72 |
| FSS | 52 / 100 |
| Listing Probability | 52% |
| Crash Risk | 48% |
🤖 Biopol Chemicals IPO Smart Money Signals
- Institutional participation: Low to Moderate
- Retail interest: High
- HNI activity: Moderate
- Smart money accumulation: Weak to Moderate
⚠️ Biopol Chemicals IPO Retail Trap Detector
High retail subscription with weak QIB participation indicates elevated speculative risk typical of SME IPO cycles.
🎯 Biopol Chemicals IPO Investor Suitability
| Investor Type | Suitability |
|---|---|
| Listing Gain Traders | Medium |
| Long-Term Investors | Low |
| High-Risk Traders | Suitable |
🔗 Biopol Chemicals IPO Internal Link Hub
| Category | Links |
|---|---|
| IPO GMP | All IPO GMP Updates |
| SME IPO | SME IPO Analysis |
🔎 Biopol Chemicals IPO SEO Keywords
Biopol Chemicals IPO GMP, Biopol Chemicals IPO subscription, Biopol Chemicals IPO review, Biopol Chemicals IPO listing price, Biopol Chemicals IPO allotment, Biopol Chemicals IPO grey market premium.
❓ Biopol Chemicals IPO FAQ
What is GMP today? ₹18–₹22
Is this IPO good? Moderate-risk SME issue.
Expected listing price? ₹92–₹108.
🏆 Biopol Chemicals IPO Final Verdict – Positional Calls
Biopol Chemicals IPO shows moderate listing upside driven primarily by retail demand, while institutional participation remains limited. This indicates speculative momentum rather than strong smart money accumulation. Investors should approach the IPO with strict risk management and realistic expectations typical of SME listings.
About The Author
